How do we best employ animal models for type 1 diabetes and multiple sclerosis?
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Boston, Mass.
Name of Publisher, Distributor, etc.
Blackwell Pub. on behalf of the New York Academy of Sciences
Date of Publication, Distribution, etc.
2007
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
xii, 220 p.: ill.)some col.(; 23 cm.
SERIES
Series Title
Annals of the New York Academy of Sciences, 7700-3298
ISSN of Series
v. 1103
GENERAL NOTES
Text of Note
Includes bibliographical references and index
CONTENTS NOTE
Text of Note
Are insights gained from NOD mice sufficient to guide clinical translation? another inconvenient truth / by Bart O. Roep -- Building different mouse models for human MS / by Estelle Bettelli -- Autoimmunity and ]beta[ cell regeneration in mouse and human type 1 diabetes: the peace is not enough / by Vitaly Ablamunits ... ]et al.[ -- Diabetes research in jeopardy: the extinction of clinical diabetes researchers / by Aldo A. Rossini and Dale L. Greiner -- The virtual NOD mouse: applying predictive biosimulation to research in type 1 diabetes / by Yanan Zheng ... ]et al.[ -- Dosing and timing effects of anti-CD04L therapy: predictions from a mathematical model of type 1 diabetes / by Kapil G. Gadkar ... ]et al.[ -- Autoreactive T cells in a partially humanized murine model of T1D / by John A Gebe ... ]et al.[ -- Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research / by Leonard D. Shultz ... ]et al.[ -- Development of new-generation HU-PBMC-NOD/SCID mice to study human islet alloreactivity / by Marie King ... ]et al.[ -- Resistance to the induction of mixed chimerism in spontaneously diabetic NOD mice depends on the CD04/CD451 pathway and donor MHC disparity / by Bin Luo ... ]et al.[ -- "Humanized" HLA transgenic NOD mice to identify pancreatic ]beta[ cell autoantigens of potential clinical relevance to type 1 diabetes / by David V. Serreze, Michele P. Marron, and Teresa P. DiLorenzo -- A new humanized HLA transgenic mouse model of multiple sclerosis expressing class II on mouse CD4 T cells / by Ashutosh Mangalam, Moses Rodriguez, and Chella David --Are insights gained from NOD mice sufficient to guide clinical translation? another inconvenient truth / by Bart O. Roep -- Building different mouse models for human MS / by Estelle Bettelli -- Autoimmunity and ]beta[ cell regeneration in mouse and human type 1 diabetes: the peace is not enough / by Vitaly Ablamunits ... ]et al.[ -- Diabetes research in jeopardy: the extinction of clinical diabetes researchers / by Aldo A. Rossini and Dale L. Greiner -- The virtual NOD mouse: applying predictive biosimulation to research in type 1 diabetes / by Yanan Zheng ... ]et al.[ -- Dosing and timing effects of anti-CD04L therapy: predictions from a mathematical model of type 1 diabetes / by Kapil G. Gadkar ... ]et al.[ -- Autoreactive T cells in a partially humanized murine model of T1D / by John A Gebe ... ]et al.[ -- Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research / by Leonard D. Shultz ... ]et al.[ -- Development of new-generation HU-PBMC-NOD/SCID mice to study human islet alloreactivity / by Marie King ... ]et al.[ -- Resistance to the induction of mixed chimerism in spontaneously diabetic NOD mice depends on the CD04/CD451 pathway and donor MHC disparity / by Bin Luo ... ]et al.[ -- "Humanized" HLA transgenic NOD mice to identify pancreatic ]beta[ cell autoantigens of potential clinical relevance to type 1 diabetes / by David V. Serreze, Michele P. Marron, and Teresa P. DiLorenzo -- A new humanized HLA transgenic mouse model of multiple sclerosis expressing class II on mouse CD4 T cells / by Ashutosh Mangalam, Moses Rodriguez, and Chella David --